Continuous Flow Synthesis of A2E

Continuous flow reactor conditions significantly optimize synthetic A2E production, reducing reaction time 87-fold and increasing yield from 49% to 78%.
Technology No. 2022-THOM-69651

Researchers at Purdue University have developed a set of reaction conditions to optimize production of N-Retinylidene-N-retinylethanolamine (A2E). A2E forms lipid deposits in the retinal pigment epithelium, causing vision impairment and blindness in eye conditions such as Stargardt's disease, cone-rod dystrophy, Best's macular dystrophy, and potentially age-related macular degeneration. Synthetic A2E is often used to simulate vision impairment in vitro, providing insights into the mechanisms of these eye conditions. Purdue researchers have modified the conventional one-pot reaction conditions for production of synthetic A2E to optimize yield. In a continuous flow reactor, the researchers obtained an 87-fold reduction in reaction time, from 48 hours to 33 minutes, with an accompanying yield improvement from 49% to 78%.

TRL: 3

Intellectual Property:

Provisional-Gov. Funding, 2021-11-22, United States | PCT-Gov. Funding, 2022-11-22, WO | NATL-Patent, 2024-05-20, United States

Keywords: N-Retinylidene-N-retinylethanolamine, A2E synthesis, continuous flow reactor, flow chemistry, reaction optimization, Stargardt's disease, macular degeneration, vision impairment, retinal disease research, lipofuscin accumulation

  • expand_more mode_edit Authors (4)
    Kalpita Bannerjee
    Giulia Murbach de Oliveira
    Marcelo Nociari
    David Harley Thompson
  • expand_more cloud_download Supporting documents (1)
    Product brochure
    Continuous Flow Synthesis of A2E.pdf
Questions about this technology?